FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for naloxone hydrochloride, a generic product, under ANDA070299.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Intoxication
• Opioid Overdose
• Opioid-induced Respiratory Depression

Drugs mentioned

• Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALXONE HYDROCHLORIDE)